Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)

China · Delayed Price · Currency is CNY

17.78

-0.24 (-1.33%)

Sep 11, 2026, 3:00 PM CST

SHA:600645 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,398	1,455	1,585	1,590	1,555	1,535
Revenue Growth	-6.77%	-8.23%	-0.27%	2.24%	1.27%	16.41%
Gross Profit	978.6	996.22	1,088	1,085	1,045	1,061
Operating Income	167.9	153.18	163.2	138.14	142.93	124.44
Net Income	117.11	113.83	100.35	106.45	112.99	155.32
Earnings Per Share	0.25	0.25	0.22	0.23	0.24	0.33
EPS Growth	51.57%	13.64%	-4.35%	-4.17%	-27.27%	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Service Industry	419.31
Manufacturing Industry	1,036
Total	1,455

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,818	1,722	1,528	1,581	1,393	1,196
Total Debt	68.68	80.27	123.75	127.48	141.18	82.2
Net Cash (Debt)	1,749	1,642	1,404	1,454	1,252	1,113
Net Cash Growth	15.86%	16.94%	-3.42%	16.09%	12.46%	11.14%
Net Cash Per Share	3.74	3.61	3.08	3.14	2.66	2.37

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	323.2	313.63	285.19	299.02	261.89	320.96
Capital Expenditures	-44.87	-49.56	-67.32	-88.61	-99.19	-127.74
Free Cash Flow	278.33	264.07	217.87	210.4	162.7	193.22
Free Cash Flow Growth	7.17%	21.21%	3.55%	29.32%	-15.79%	26.59%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	70.00%	68.47%	68.61%	68.23%	67.18%	69.14%
Operating Margin	12.01%	10.53%	10.29%	8.69%	9.19%	8.11%
Pretax Margin	13.39%	11.99%	8.57%	8.34%	9.98%	14.52%
Profit Margin	8.38%	7.82%	6.33%	6.70%	7.27%	10.12%
FCF Margin	19.91%	18.15%	13.74%	13.23%	10.46%	12.58%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	72.00	100.93	87.68	89.10	70.45	76.04
Forward PE	-	72.92	56.77	48.99	48.99	48.99
P/FCF Ratio	29.52	43.51	40.39	45.08	48.92	61.13
PS Ratio	5.88	7.90	5.55	5.97	5.12	7.69